Phase 2 Psoriatic Arthritis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You are willing and able to follow all the procedures required by the study.
• You have been formally diagnosed with Psoriatic Arthritis (PsA) for at least 6 months before the screening visit, and your diagnosis meets a specific set of classification standards checked at screening.
• You have active disease, meaning you have at least 3 tender joints and at least 3 swollen joints, confirmed at both your screening visit and the start of the study.
• You have active plaque psoriasis (a skin condition causing scaly patches) and/or a documented history of it.
• You have already tried 1 to 2 approved targeted treatments (biological or targeted synthetic medications) for PsA, but either could not tolerate them or they did not work well enough for you.

Who may not be able to join:

• You have had major surgery within the 12 weeks before joining the study, or you plan to have major surgery during the study.
• You currently have HIV, active Hepatitis B, active Hepatitis C, or active tuberculosis (TB).
• You have an active skin condition other than psoriasis that could make it difficult to properly assess your skin during the study.
• You have a history of fibromyalgia, any form of arthritis that started before age 17, or any other inflammatory joint disease besides PsA — such as rheumatoid arthritis, gout, lupus, or related conditions.

Important: Always verify eligibility with the trial site directly before applying.